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Recent advances in cell line development and in the design of culture media have significantly increased both 
the volumetric and specific productivity of fed batch processes, which is our standard platform technology for 
synthesis of therapeutic proteins.  Cell culture processes are generally simplified when needed as a robust 
platform technology to meet the imperatives of speedy timelines for early process development and ease of 
manufacturing.  However, both culture media and feeding strategies need to be customized for specific cell lines 
when there is a need to achieve higher titer due to higher product demand. This presentation will focus on the 
specific changes that were made in order to enhance the platform cell culture process for achieving much higher 
titers.  A case study will be used to demonstrate that changes made to feeding strategy, feed media and other 
process parameters have the potential to maximize productivity but also to alter the product quality profile.  It is 
critical to ensure that these process changes do not adversely impact product quality.  Strategies used to control 
the acidic charge variant profile, which was elevated in these enhanced cell culture processes, will be 
discussed. 
 
 
